SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+18.51%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$447M
AUM Growth
+$447M
(+0.78%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
48.85%
Holding
81
New
11
Increased
34
Reduced
11
Closed
21
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
$17.3M |
| 2 |
Syndax Pharmaceuticals
SNDX
|
$11.3M |
| 3 |
Scholar Rock
SRRK
|
$7.92M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$7.76M |
| 5 |
Ascendis Pharma
ASND
|
$6.4M |
Top Sells
| 1 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
$25.7M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$9.84M |
| 3 |
Protagonist Therapeutics
PTGX
|
$6.6M |
| 4 |
Sarepta Therapeutics
SRPT
|
$6.4M |
| 5 |
ADC Therapeutics
ADCT
|
$5.65M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Sarepta Therapeutics
SRPT
$1.77B
| – | – |
-51,245
| Closed | -$6.4M |
|
77
Instil Bio
TIL
$197M
| – | – |
-10,517
| Closed | -$708K |
|
78
Xencor
XNCR
$610M
| – | – |
-75,507
| Closed | -$1.52M |
|
79
Zevra Therapeutics
ZVRA
$511M
| – | – |
-350,000
| Closed | -$2.43M |
|
|
MTEM
80
DELISTED
Molecular Templates, Inc.
MTEM
| – | – |
-623,838
| Closed | -$876K |
|
|
LBPH
81
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| – | – |
-124,353
| Closed | -$4.14M |
|